HIV2 GP36 antibody
- Known as:
- HIV2 GP36 (anti-)
- Catalog number:
- 10-2653
- Product Quantity:
- 500 ug
- Category:
- -
- Supplier:
- Fitzgerald
- Gene target:
- HIV2 GP36 antibody
Ask about this productRelated genes to: HIV2 GP36 antibody
- Gene:
- LMAN2 NIH gene
- Name:
- lectin, mannose binding 2
- Previous symbol:
- C5orf8
- Synonyms:
- GP36B, VIP36
- Chromosome:
- 5q35.3
- Locus Type:
- gene with protein product
- Date approved:
- 2001-10-18
- Date modifiied:
- 2016-10-05
Related products to: HIV2 GP36 antibody
Related articles to: HIV2 GP36 antibody
- Breast cancer (BC), the most widespread malignancy in women globally, is characterized by complex and heterogeneous mechanisms. Lectin, mannose binding 2 (LMAN2), a potential oncogene highly expressed in BC, is linked to poor prognosis. The transcription factor forkhead box protein A1 (FOXA1) is often overexpressed in BC and tied to malignant phenotypes, but how it regulates LMAN2 to influence BC progression remains unclear. - Source: PubMed
Publication date: 2026/08/22
Zhang ZhitaoWang ShaoyunSun HaifengYu Yinping - Dysregulated lipid metabolism and chemoresistance are key drivers of breast cancer progression. Lectin, mannose-binding 2 (LMAN2) is frequently overexpressed in human breast tumors and functions as an oncogenic driver. However, whether LMAN2 contributes to chemoresistance remains unknown. - Source: PubMed
Publication date: 2026/07/08
Yan ChangjiaoCui FengqiangLiu ChutuoLing RuiHuang MeilingWang Ting - Earlier research observed the effects of plasma proteins on ischemic stroke (IS). This Mendelian randomization (MR), in vivo study additionally assesses the associations of localized populations of plasma proteins with IS to further confirm the causality and explore drug targets. - Source: PubMed
Publication date: 2026/03/17
Ren HaoxuDing YingyueWang RuonanLi JinjianYang ChenganWang XuZhao Dexi - Gout is a prevalent inflammatory arthropathy driven by monosodium urate crystal deposition, yet the causal relationships between circulating biomarkers and disease susceptibility remain incompletely characterized. Establishing robust causal associations and mapping them to specific effector genes and tissues is essential for identifying mechanistically informed therapeutic targets. - Source: PubMed
Publication date: 2026/02/24
Huang LiangLiu JianiZheng XiaohuiZhang KaiChen YixinChen XiaolingZhang SiqiCai ShanshanCai LiGuo YanyanZhu PengLi Meng - Heart failure (HF) and its main subtypes, heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF), impose an enormous health burden on elders. Assessment of the circulating proteome to illuminate pathogenesis could open new opportunities for treatment. - Source: PubMed
Publication date: 2026/02/04
Njoroge Joyce NSanders van Wijk SandraAustin Thomas RBrody Jennifer ASitlani Colleen MHamerton EmilyBis Joshua CHenry AlbertLumbers R Thomas Seshaiah TaliaShojaie AliYang YiminLamberson VictoriaYu BingShah Amil MBansal NishaShah Sanjiv JTracy Russell PGerszten Robert EJennings Lori LGudmundsdottir ValborgGudnason VilmundurEmilsson ValurPsaty Bruce MKizer Jorge R